APPLICATION
ANDA064127
TYPE
ANDA
ORIGINAL APPROVAL
1997-02-14
LATEST ACTION
1997-02-14
ROUTE
TOPICAL
DOSAGE FORM
SOLUTION
MARKETING STATUS
Discontinued
Products
ERYTHROMYCINDiscontinued
ERYTHROMYCIN 2% · SOLUTION · TOPICAL
Approval history
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.